HERA Stock Overview
FTAC Hera Acquisition Corp. does not have significant operations.
FTAC Hera Acquisition Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$9.91|
|52 Week High||US$9.92|
|52 Week Low||US$9.68|
|1 Month Change||0.51%|
|3 Month Change||1.07%|
|1 Year Change||1.85%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-0.20%|
Recent News & Updates
|HERA||US Capital Markets||US Market|
Return vs Industry: HERA exceeded the US Capital Markets industry which returned -25.7% over the past year.
Return vs Market: HERA exceeded the US Market which returned -23% over the past year.
|HERA Average Weekly Movement||0.2%|
|Capital Markets Industry Average Movement||0.5%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.7%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: HERA is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 0% a week.
Volatility Over Time: HERA's weekly volatility (0%) has been stable over the past year.
About the Company
FTAC Hera Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Philadelphia, Pennsylvania.
FTAC Hera Acquisition Fundamentals Summary
|HERA fundamental statistics|
Is HERA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HERA income statement (TTM)|
|Cost of Revenue||US$0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.22|
|Net Profit Margin||0.00%|
How did HERA perform over the long term?See historical performance and comparison
Is HERA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HERA?
Other financial metrics that can be useful for relative valuation.
|What is HERA's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does HERA's PE Ratio compare to its peers?
|HERA PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
CPUH Compute Health Acquisition
AUS Austerlitz Acquisition Corporation I
BBDC Barings BDC
CRHC Cohn Robbins Holdings
HERA FTAC Hera Acquisition
Price-To-Earnings vs Peers: HERA is expensive based on its Price-To-Earnings Ratio (45.9x) compared to the peer average (43x).
Price to Earnings Ratio vs Industry
How does HERA's PE Ratio compare vs other companies in the US Capital Markets Industry?
Price-To-Earnings vs Industry: HERA is expensive based on its Price-To-Earnings Ratio (45.9x) compared to the US Capital Markets industry average (25x)
Price to Earnings Ratio vs Fair Ratio
What is HERA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||45.9x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HERA's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of HERA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate HERA's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate HERA's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is FTAC Hera Acquisition forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Diversified Financials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as FTAC Hera Acquisition has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Take a look at our analysis of HERA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
How has FTAC Hera Acquisition performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical Diversified Financials annual earnings growth
Earnings and Revenue History
Quality Earnings: HERA has high quality earnings.
Growing Profit Margin: Insufficient data to determine if HERA's profit margins have improved over the past year.
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if HERA's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare HERA's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: Insufficient data to determine if HERA's earnings growth over the past year exceeded the Capital Markets industry average.
Return on Equity
High ROE: HERA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Discover strong past performing companies
How is FTAC Hera Acquisition's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: HERA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: HERA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: HERA is debt free.
Reducing Debt: HERA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: HERA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: HERA has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is FTAC Hera Acquisition current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
|FTAC Hera Acquisition Dividend Yield vs Market|
|Company (FTAC Hera Acquisition)||n/a|
|Market Bottom 25% (US)||1.7%|
|Market Top 25% (US)||4.7%|
|Industry Average (Capital Markets)||2.9%|
|Analyst forecast in 3 Years (FTAC Hera Acquisition)||n/a|
Notable Dividend: Unable to evaluate HERA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HERA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HERA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HERA's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as HERA has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Daniel Cohen (53 yo)
Mr. Daniel Gideon Cohen serves as Chairman of FTAC Zeus Acquisition Corp. since December 2020. Mr. Gideon serves as Independent Director of Perella Weinberg Partners since June 24, 2021. Mr. Cohen serves a...
Experienced Board: HERA's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
FTAC Hera Acquisition Corp.'s employee growth, exchange listings and data sources
- Name: FTAC Hera Acquisition Corp.
- Ticker: HERA
- Exchange: NasdaqCM
- Founded: 2021
- Industry: Asset Management and Custody Banks
- Sector: Diversified Financials
- Implied Market Cap: US$1.079b
- Shares outstanding: 108.83m
- Website: https://fintechmasala.com/investments/hera-acquisition-corp/default.aspx
- FTAC Hera Acquisition Corp.
- 2929 Arch Street
- Suite 1703
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|HERA.U||NasdaqCM (Nasdaq Capital Market)||Units||US||USD||Mar 2021|
|HERA||NasdaqCM (Nasdaq Capital Market)||Yes||Class A Ordinary Shares||US||USD||Apr 2021|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/26 00:00|
|End of Day Share Price||2022/09/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.